These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36638354)

  • 41. A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada.
    Beaulieu C; Lui A; Yusuf D; Abdelaziz Z; Randolph B; Batuyong E; Ghosh S; Bathe OF; Tam V; Spratlin JL
    Curr Oncol; 2021 Jan; 28(1):417-427. PubMed ID: 33450805
    [No Abstract]   [Full Text] [Related]  

  • 42. Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017.
    Ellington TD; Momin B; Wilson RJ; Henley SJ; Wu M; Ryerson AB
    Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1607-1614. PubMed ID: 34244156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in biliary tract cancer.
    Nectoux J; Coleman MP
    Rev Epidemiol Sante Publique; 1993; 41(2):113-22. PubMed ID: 8493389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine-Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX-BC Study).
    Okano N; Furuse J; Ueno M; Morizane C; Yamanaka T; Ojima H; Ozaka M; Sasaki M; Takahara N; Nakai Y; Kobayashi S; Morimoto M; Hosoi H; Maeno S; Nagashima F; Ikeda M; Okusaka T
    Oncologist; 2021 Feb; 26(2):97-e201. PubMed ID: 33010112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Carcinoma of the biliary tract].
    Miyazaki I; Konishi I; Nagakawa T
    Gan No Rinsho; 1986 Aug; 32(10):1365-8. PubMed ID: 3783969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis.
    Hamura R; Haruki K; Taniai T; Yanagaki M; Shirai Y; Furukawa K; Usuba T; Fujioka S; Okamoto T; Nakabayashi Y; Uwagawa T; Ikegami T
    Int J Clin Oncol; 2022 Jul; 27(7):1188-1195. PubMed ID: 35426581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical relevance of the new S3 guideline on hepatocellular carcinoma and biliary tract cancer for practitioners].
    Voesch S; Bitzer M; Malek N
    Radiologe; 2022 Mar; 62(3):200-204. PubMed ID: 35147708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
    Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
    Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Will advanced cholangiocarcinoma become a targetable malignancy?
    Sarkis Y; Al Soueidy A; Kourie HR
    Crit Rev Oncol Hematol; 2021 Mar; 159():103233. PubMed ID: 33482346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database.
    Kim BW; Oh CM; Choi HY; Park JW; Cho H; Ki M
    Gut Liver; 2019 Jan; 13(1):104-113. PubMed ID: 29938462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rare cancer, rare alteration: the case of NTRK fusions in biliary tract cancers.
    Boilève A; Verlingue L; Hollebecque A; Boige V; Ducreux M; Malka D
    Expert Opin Investig Drugs; 2021 Apr; 30(4):401-409. PubMed ID: 33641556
    [No Abstract]   [Full Text] [Related]  

  • 52. Usefulness of bile cytology in the diagnostic management of patients with biliary tract obstruction.
    Cobb CJ; Floyd WN
    Acta Cytol; 1985; 29(2):93-100. PubMed ID: 2984868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial.
    Bengala C; Bertolini F; Malavasi N; Boni C; Aitini E; Dealis C; Zironi S; Depenni R; Fontana A; Del Giovane C; Luppi G; Conte P
    Br J Cancer; 2010 Jan; 102(1):68-72. PubMed ID: 19935794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Advance in immunotherapy on biliary tract cancers].
    Liu LG; Zhang YJ; Wang XA; Liu YB
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):156-160. PubMed ID: 33378809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy?
    Miwa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Ogawa S; Soeda J; Miyagawa S
    J Hepatobiliary Pancreat Surg; 2007; 14(2):136-41. PubMed ID: 17384903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial.
    Klein O; Kee D; Nagrial A; Markman B; Underhill C; Michael M; Jackett L; Lum C; Behren A; Palmer J; Tebbutt NC; Carlino MS; Cebon J
    JAMA Oncol; 2020 Sep; 6(9):1405-1409. PubMed ID: 32729929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination versus mono-therapy as salvage treatment for advanced biliary tract cancer: A comprehensive meta-analysis of published data.
    Ying J; Chen J
    Crit Rev Oncol Hematol; 2019 Jul; 139():134-142. PubMed ID: 30979533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study.
    Ueno M; Ikeda M; Morizane C; Kobayashi S; Ohno I; Kondo S; Okano N; Kimura K; Asada S; Namba Y; Okusaka T; Furuse J
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):611-621. PubMed ID: 31109808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008.
    Yang JD; Kim B; Sanderson SO; Sauver JS; Yawn BP; Larson JJ; Therneau TM; Roberts LR; Gores GJ; Kim WR
    Am J Gastroenterol; 2012 Aug; 107(8):1256-62. PubMed ID: 22751468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study.
    Kajanti M; Pyrhönen S
    Am J Clin Oncol; 1994 Jun; 17(3):223-6. PubMed ID: 8192106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.